Tags

Type your tag names separated by a space and hit enter

Agmatine Protects Against 6-OHDA-Induced Apoptosis, and ERK and Akt/GSK Disruption in SH-SY5Y Cells.
Cell Mol Neurobiol. 2016 Aug; 36(6):829-838.CM

Abstract

6-Hydroxydopamine (6-OHDA), a metabolite of dopamine is known to induce dopaminergic cell toxicity which makes that a suitable agent inducing an experimental model of Parkinson's disease (PD). Agmatine has been shown to protect against some cellular and animal PD models. This study was aimed to assess whether agmatine prevents 6-OHDA-induced SH-SY5Y cell death and if yes, then how it affects Akt/glycogen synthesis kinase-3β (GSK-3β) and extracellular signal-regulated kinases (ERK) signals. The cells were treated with different drugs, and their viability was examined via MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide) assay and morphological observation. Western blot studies were done to assess cleaved caspase-3, Akt/GSK-3β, and ERK proteins. 6-OHDA-induced cell death and caspase-3 cleavage, while agmatine prevented those changes. 6-OHDA also decreased the amount of phosphorylated Akt (pAkt)/Akt while increased GSK-3β activity which was prevented by agmatine. Additionally, this toxin increased pERK/ERK ratio which was averted again by agmatine. The PI3/Akt inhibitor, LY294002, impeded the changes induced by agmatine, while ERK inhibitor (PD98059) did not disturb the effects of agmatine, and by itself, it preserved the cells against 6-OHDA toxicity. This study revealed that agmatine is protective in 6-OHDA model of PD and affects Akt/GSK-3β and ERK pathways.

Authors+Show Affiliations

Department of Physiology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.Department of Physiology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Neurophysiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.Department of Physiology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. marmoosavi@sums.ac.ir. Nanotechnology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. marmoosavi@sums.ac.ir.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

26346882

Citation

Amiri, Esmat, et al. "Agmatine Protects Against 6-OHDA-Induced Apoptosis, and ERK and Akt/GSK Disruption in SH-SY5Y Cells." Cellular and Molecular Neurobiology, vol. 36, no. 6, 2016, pp. 829-838.
Amiri E, Ghasemi R, Moosavi M. Agmatine Protects Against 6-OHDA-Induced Apoptosis, and ERK and Akt/GSK Disruption in SH-SY5Y Cells. Cell Mol Neurobiol. 2016;36(6):829-838.
Amiri, E., Ghasemi, R., & Moosavi, M. (2016). Agmatine Protects Against 6-OHDA-Induced Apoptosis, and ERK and Akt/GSK Disruption in SH-SY5Y Cells. Cellular and Molecular Neurobiology, 36(6), 829-838. https://doi.org/10.1007/s10571-015-0266-7
Amiri E, Ghasemi R, Moosavi M. Agmatine Protects Against 6-OHDA-Induced Apoptosis, and ERK and Akt/GSK Disruption in SH-SY5Y Cells. Cell Mol Neurobiol. 2016;36(6):829-838. PubMed PMID: 26346882.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Agmatine Protects Against 6-OHDA-Induced Apoptosis, and ERK and Akt/GSK Disruption in SH-SY5Y Cells. AU - Amiri,Esmat, AU - Ghasemi,Rasoul, AU - Moosavi,Maryam, Y1 - 2015/09/07/ PY - 2015/06/23/received PY - 2015/08/29/accepted PY - 2015/9/9/entrez PY - 2015/9/9/pubmed PY - 2017/3/23/medline KW - 6-OHDA KW - Akt KW - Caspase-3 KW - ERK KW - GSK-3β KW - SH-SY5Y SP - 829 EP - 838 JF - Cellular and molecular neurobiology JO - Cell Mol Neurobiol VL - 36 IS - 6 N2 - 6-Hydroxydopamine (6-OHDA), a metabolite of dopamine is known to induce dopaminergic cell toxicity which makes that a suitable agent inducing an experimental model of Parkinson's disease (PD). Agmatine has been shown to protect against some cellular and animal PD models. This study was aimed to assess whether agmatine prevents 6-OHDA-induced SH-SY5Y cell death and if yes, then how it affects Akt/glycogen synthesis kinase-3β (GSK-3β) and extracellular signal-regulated kinases (ERK) signals. The cells were treated with different drugs, and their viability was examined via MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide) assay and morphological observation. Western blot studies were done to assess cleaved caspase-3, Akt/GSK-3β, and ERK proteins. 6-OHDA-induced cell death and caspase-3 cleavage, while agmatine prevented those changes. 6-OHDA also decreased the amount of phosphorylated Akt (pAkt)/Akt while increased GSK-3β activity which was prevented by agmatine. Additionally, this toxin increased pERK/ERK ratio which was averted again by agmatine. The PI3/Akt inhibitor, LY294002, impeded the changes induced by agmatine, while ERK inhibitor (PD98059) did not disturb the effects of agmatine, and by itself, it preserved the cells against 6-OHDA toxicity. This study revealed that agmatine is protective in 6-OHDA model of PD and affects Akt/GSK-3β and ERK pathways. SN - 1573-6830 UR - https://www.unboundmedicine.com/medline/citation/26346882/Agmatine_Protects_Against_6_OHDA_Induced_Apoptosis_and_ERK_and_Akt/GSK_Disruption_in_SH_SY5Y_Cells_ L2 - https://doi.org/10.1007/s10571-015-0266-7 DB - PRIME DP - Unbound Medicine ER -